These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9335081

  • 1. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 2. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 3. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 4. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 5. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
    Kellner M, Muhtz C, Stark K, Yassouridis A, Arlt J, Wiedemann K.
    Psychopharmacology (Berl); 2005 Apr; 179(1):310-5. PubMed ID: 15821951
    [Abstract] [Full Text] [Related]

  • 6. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R.
    Biol Psychiatry; 2000 Jan 15; 47(2):107-11. PubMed ID: 10664826
    [Abstract] [Full Text] [Related]

  • 8. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 15; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 9. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ, Koszycki D, Bradwejn J, Vaccarino FJ.
    Psychoneuroendocrinology; 2000 Aug 15; 25(6):633-47. PubMed ID: 10840174
    [Abstract] [Full Text] [Related]

  • 10. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, Jahn H, Wiedemann K, Wolf K.
    J Psychiatr Res; 2010 Dec 15; 44(16):1148-53. PubMed ID: 20451215
    [Abstract] [Full Text] [Related]

  • 11. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Dec 15; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 12. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May 15; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 13. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb 15; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 14. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
    van Megen HJ, Westenberg HG, den Boer JA, Slaap B, van Es-Radhakishun F, Pande AC.
    Psychopharmacology (Berl); 1997 Feb 15; 129(3):243-8. PubMed ID: 9084062
    [Abstract] [Full Text] [Related]

  • 15. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D, Zacharko RM, Le Mellédo JM, Bradwejn J.
    Depress Anxiety; 1998 Feb 15; 8(1):1-7. PubMed ID: 9750972
    [Abstract] [Full Text] [Related]

  • 16. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, Karkanias C.
    Biol Psychiatry; 1992 Nov 15; 32(10):903-12. PubMed ID: 1467375
    [Abstract] [Full Text] [Related]

  • 17. Clonidine in respiratory panic disorder subtype.
    Valença AM, Nardi AE, Mezzasalma MA, Nascimento I, Lopes FL, Zin WA, Versiani M.
    Arq Neuropsiquiatr; 2004 Jun 15; 62(2B):396-8. PubMed ID: 15273833
    [Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges.
    Kronenberg G, Berger P, Tauber RF, Bandelow B, Henkel V, Heuser I.
    Pharmacopsychiatry; 2005 Jan 15; 38(1):24-9. PubMed ID: 15706463
    [Abstract] [Full Text] [Related]

  • 19. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M, Fuertig R, Mack SR, Just S, Sharma V, Wunder A, den Boer J.
    CNS Drugs; 2023 Dec 15; 37(12):1099-1109. PubMed ID: 38019356
    [Abstract] [Full Text] [Related]

  • 20. The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4.
    Le Mellédo JM, Arthur H, Dalton J, Woo C, Lipton N, Bellavance F, Koszycki D, Boulenger JP, Bradwejn J.
    J Psychosom Res; 2001 Sep 15; 51(3):513-20. PubMed ID: 11602221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.